Education
About Us
Working with TipRanks
Follow Us
Terns Pharmaceuticals (TERN)
NASDAQ:TERN
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 1.00M | $ 0.00 |
| Gross Profit | $ 0.00 | $ -881.00K | $ -1.03M | $ 488.00K | $ -394.00K |
| Operating Income | $ -101.87M | $ -102.56M | $ -62.03M | $ -49.86M | $ -37.02M |
| EBITDA | $ -101.87M | $ -102.27M | $ -58.95M | $ -49.35M | $ -36.63M |
| Net Income | $ -88.85M | $ -90.21M | $ -60.34M | $ -50.16M | $ -40.57M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 358.16M | $ 263.44M | $ 283.11M | $ 165.98M | $ 74.85M |
| Total Assets | $ 363.93M | $ 268.52M | $ 287.03M | $ 168.07M | $ 92.29M |
| Total Debt | $ 1.35M | $ 603.00K | $ 1.21M | $ 0.00 | $ 12.88M |
| Net Debt | $ -160.09M | $ -79.32M | $ -142.03M | $ -47.70M | $ -61.97M |
| Total Liabilities | $ 18.06M | $ 13.15M | $ 10.08M | $ 7.77M | $ 23.70M |
| Stockholders' Equity | $ 345.87M | $ 255.37M | $ 276.94M | $ 160.30M | $ 68.59M |
| Cash Flow | |||||
| Free Cash Flow | $ -70.06M | $ -67.44M | $ -49.38M | $ -42.17M | $ -30.39M |
| Operating Cash Flow | $ -70.02M | $ -67.39M | $ -49.11M | $ -41.83M | $ -29.81M |
| Investing Cash Flow | $ -12.41M | $ -37.99M | $ -22.27M | $ -119.70M | $ 6.69M |
| Financing Cash Flow | $ 164.00M | $ 41.95M | $ 167.50M | $ 134.39M | $ 85.52M |